SCHEMBL23864113

SCHEMBL23864113

COc1cccc2nnn(CC(C)=O)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR139 Q6DWJ6 7/20 0.45
▸ TSHR P16473 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MGAM O43451 2/20 0.43
▸ AMY1A P0DUB6 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ SI P14410 2/20 0.43
▸ MGAM2 Q2M2H8 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ F12 P00748 1/20 0.43
▸ MIF P14174 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ PTK2 Q05397 1/20 0.40
▸ HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3408540 0.73 TSHR (0.46) TSHRHSD17B10KDM4ELMNANPC1
SCHEMBL17767164 0.73 GPR139 (0.64) GPR139TSHRHSD17B10NPSR1
SCHEMBL1689837 0.72 GAA (0.67) HSD17B10MGAMAMY1AGAASI
SCHEMBL38666254 0.72 KEAP1 (0.46) HSD17B10KDM4EMGAMAMY1AGAA
SCHEMBL23361234 0.71 NPC1 (0.43) GPR139LMNANPC1RAB9APTK2
SCHEMBL11983636 0.69 ALDH1A1 (0.68) GPR139HSD17B10GAANPC1RAB9A
SCHEMBL13963730 0.69 FAAH (0.45) HSD17B10KDM4ELMNAMGAMAMY1A
SCHEMBL17767225 0.64 GPR139 (0.64) GPR139TSHRHSD17B10NPSR1
SCHEMBL13032599 0.62 CYP3A4 (0.50) HSD17B10KDM4ELMNAALDH1A1MAPT
SCHEMBL202954 0.62 KMO (0.63) GPR139MGAMAMY1AGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3885352-A1 A COMPOUND, COMPOSITIONS THEREOF AND THIS COMPOUND FOR USE IN METHODS OF TREATING CNS DISORDERS Sage Therapeutics, Inc. (US) 2021-09-29 — — EP disclosed
Send feedback